Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04494048 · ClinicalTrials.gov registry record

Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry

A clinical trial of Obesity and Weight Loss, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
1
Study location

NCT04494048 is a study of Obesity and Weight Loss that is actively recruiting participants, run by Weill Medical College of Cornell University. The registry lists this as an open-ended (no fixed target) study. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04494048, a study of Obesity and Weight Loss, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
open-ended (no fixed target)
Enrollment target
1
Study location

Study Summary

The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care visits up to 1 years after a subject consents for study participation.

Interventions

  • OTHER Endoscopic Bariatric Therapies

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target open-ended (no fixed target)
Start Date 2016-04-05
Est. Completion 2035-10-31

What the Registry Record Tells You About NCT04494048

The ClinicalTrials.gov registry entry for NCT04494048 describes a study currently listed as recruiting, categorized as an unspecified phase. The registry lists this as an open-ended (no fixed target) study, common for long-running registries and repositories that collect data indefinitely rather than recruiting toward a fixed participant count. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Bariatric Therapies is the first listed.

NCT04494048 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04494048 about?

NCT04494048 is a clinical study titled "Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry". The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care vis...

What is the current status of trial NCT04494048?

This trial is currently recruiting. The enrollment target is open-ended (no fixed target). The study started on 2016-04-05. Estimated completion is 2035-10-31.

What conditions does trial NCT04494048 study?

This clinical trial studies the following conditions: Obesity, Weight Loss, Bariatric Surgery Candidate, Gastro Esophageal Reflux.

What interventions are being tested in trial NCT04494048?

The interventions under investigation include: Endoscopic Bariatric Therapies (OTHER).

Who is sponsoring clinical trial NCT04494048?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04494048 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.